Petmed Express traded at $2.90 this Thursday February 12th, decreasing $0.07 or 2.36 percent since the previous trading session. Looking back, over the last four weeks, Petmed Express lost 15.45 percent. Over the last 12 months, its price fell by 35.12 percent. Looking ahead, we forecast Petmed Express to be priced at 4.31 by the end of this quarter and at 3.93 in one year, according to Trading Economics global macro models projections and analysts expectations.
PetMed Express, Inc. is a pet pharmacy. The Company markets prescription and non-prescription pet medications, health products and supplies for dogs, cats and horses, direct to the consumer. The Company’s product line contains approximately 3,000 stock-keeping units (SKUs). It also offers sale additional pet supplies on its Website, which are drop shipped to the customers by third parties. Its product line provides customers with a range of selections across the health categories for dogs, cats and horses. The Company’s current products include Non-Prescription Medications (OTC) and supplies and Prescription Medications (Rx). OTC includes flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes Heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.